Anti Stretch Mark Products Market Size, Share - Growth Analysis Report and Forecast Trends 2026-2030

Stretch marks, or striae, are dermal scars that form when skin is stretched rapidly, and the products designed to address them span preventive body oils, corrective creams, and in-office-adjacent home care. The market was valued at approximately USD 325.4 million in 2025 and is forecast to grow at a compound annual rate of around 6.3%, with multiple independent projections placing the category between USD 2.2 billion and USD 2.6 billion by the early 2030s. Growth has been steady rather than explosive, reflecting the category's position as a niche within the much larger global skincare and body care industry.

• •2025 market value estimated at USD 325.4 million globally
• •Long-run forecasts range from USD 1.5 billion (2027) to USD 2.62 billion (2032)
• •Demand is split between preventive use during pregnancy and corrective use after striae have formed

Rising maternal and postpartum skin-care spending is one of the strongest tailwinds, as pregnant and nursing consumers increasingly seek targeted products recommended by dermatologists and obstetricians. Greater public awareness of skin health, the destigmatization of body care for men, and the rapid growth of direct-to-consumer e-commerce channels are also expanding the addressable audience for stretch mark solutions. At the same time, formulation advances that combine retinoids, peptides, hyaluronic acid, centella asiatica, and natural oils are repositioning the category from a cosmetic optionality to a more clinically credible treatment.

• •Premium pregnancy care and postpartum recovery routines are lifting average selling prices
• •Social media and influencer-led content are normalizing preventive body care for men and younger consumers
• •Inclusion of bioactive ingredients such as peptides, retinoids, and botanical extracts supports higher price points

By product type, the market is led by creams and lotions, followed by body oils, gels and serums, with newer categories like post-procedure and home-device-adjacent products emerging at the margin. End-use segmentation is dominated by pregnant consumers and postpartum women, followed by adolescents going through growth spurts, bodybuilders, and post-weight-loss patients. North America and Europe together account for the bulk of global revenue thanks to high per-capita skincare spending and strong retail pharmacy distribution, while Asia-Pacific is the fastest-growing region on the back of expanding middle-class beauty budgets in China, India, and Southeast Asia.

• •Creams and lotions remain the largest sub-category, with oils and serums growing quickly
• •Pregnancy-related applications represent the single largest end-use segment
• •Asia-Pacific is expanding faster than North America or Europe in percentage terms

What are the recent trends and outlook?

Clean-beauty and pregnancy-safe formulation standards are reshaping product development, with brands actively avoiding retinoids, certain essential oils, and other ingredients flagged as unsuitable for expectant mothers. Digital channels, including tele-dermatology consultations and AI-driven skin assessments, are being used to personalize routines and drive repeat purchase. Looking ahead, the category is expected to consolidate around clinically validated actives and trusted brand narratives, supporting sustained mid-single-digit growth through the end of the decade.

• •Pregnancy-safe and clean-label formulations are becoming a baseline expectation rather than a premium add-on
• •Personalized skincare tools and tele-dermatology are creating new education and acquisition funnels
• •6.3% CAGR is expected to hold as the category matures toward USD 2.5 billion+ globally